VirNext offers complete evaluation and characterization of the antiviral or proviral effect of specific compounds,
both in vitro and in vivo. Molecules can be evaluated on a large panel of viral strains according to the customer’s specific
VirNext accomplishes complete evaluation of impact of your compounds at different levels of concentrations on various biological supports.
Toxicity and antiviral activity evaluation of selected candidate compounds can be enhanced by combining classical laboratory and software-assisted assays.
VirNext evaluates and characterizes the proviral activities of your compounds and proposes optimized production conditions to maximize virus yield, both in cell and embryonated egg-based systems of production.
VirNext evaluates the potential emergence and temporal development of viral resistance to the specific drug of your choice.